m2p-labs

Baesweiler, Germany Founded: 2005 • Age: 21 yrs Acquired By Beckman Coulter
Micro-bioreactors are provided for screening and bioprocess development.

About m2p-labs

m2p-labs is a company based in Baesweiler (Germany) founded in 2005 was acquired by Beckman Coulter in November 2020. The company has 107 employees. m2p-labs operates in a competitive market with competitors including Limula, PBS Biotech, Membio, Innovel Intelligent Technology and Hyalose, among others.

  • Headquarter Baesweiler, Germany
  • Employees 107
  • Sectors
    Healthcare
  • Email
    ••••••••
  • Phone
    •••• ••••
  • Website m2p-labs.com
  • Social LinkedIn X Facebook
  • Acquired by Beckman Coulter (Nov 2020)
  • Legal Name M2p-Labs Gmbh
Key Metrics

Funding Insights of m2p-labs

  • Total Rounds 3
  • Investors Count 4

All 3 funding rounds of m2p-labs with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.

DateAmountTransaction NameValuationLead InvestorsInvestors
Nov 2013–Series A–FIDURA
May 2011–Seed––
Nov 2008–Seed––
Valuation history

5 investors in total: 5 institutional.

Investors in m2p-labs

m2p-labs has secured backing from 5 investors, including venture fund and institutional investors. Prominent investors backing the company include KfW, Beckman Coulter and FIDURA Private Equity Fonds.

All
Venture Fund
Institutional
InvestorDescriptionFounded YearDomainLocation
Private equity investments in mid-sized German companies are managed.
–fidura.deGrünwald, Germany
Early-stage investments are made in high-tech startups by HTGF.
–htgf.deBonn, Germany
TechVision Fonds is engaged in early-stage venture capital investments.
2007techvision-fonds.deAachen, Germany
Consumer and SME loans are provided across Germany.
1948kfw.deFrankfurt Am Main, Germany
Provider of products for biomedical testing for R&D, diagnostic and commercial applications
1935beckman.comBrea, United States
Premium access

Investor details for m2p-labs

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

Timeline of m2p-labs

4 dated milestones of m2p-labs across 15 years, from founding to its latest funding, stage changes and deals.

  1. Founded m2p-labs is founded.
  2. Funding First funding round.
  3. Funding Latest funding round, Series A,.
  4. Exit Acquired by Beckman Coulter.

Competitors of m2p-labs

m2p-labs operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Limula, PBS Biotech, Membio, Innovel Intelligent Technology and Hyalose, among others.

Company NameDomainFoundedHQ LocationTotal fundingEmployeesDescription
limula.ch2020–––
Modular solutions for on-demand cell therapy manufacturing are provided.
pbsbiotech.com2006Camarillo, United States$70.21M–
Developer of single-use bioreactors for the production of vaccines, therapeutic proteins, and cell therapies
membio.ca2018Kitchener, Canada$280,000–
Developer of single-use bioreactors for cell and gene therapies
sinoinnovel.com2018Suzhou, China$15.28M–
Bioreactors and automated systems for cell culture production are supplied.
hyalose.com2000Oklahoma, United States––
Recombinant hyaluronic acid is manufactured in varying molecular sizes.
microbiopharm.com2011Tokyo, Japan––
Contract research and discovery services are provided to biopharma firms.
atspiro.com2019Lyngby, Denmark$172,8795
Developer of an automated single-use bioreactor for fermentation and cell cultivation of microbial cells
bionet.com1999Santiago Papasquiaro, Mexico––
Manufactures bioreactors, TFF systems, and software for biopharma and agri-food applications.
Premium access

Detailed competitors of m2p-labs

The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.

  • Full competitor set
  • Operating metrics
  • Benchmarks
  • Competitive positioning

Verified entity values are shown only after access is granted.

Latest news on M2p-Labs

Premium access

Complete news archive for m2p-labs

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Similar companies to m2p-labs

10 companies that operate in the same segment as m2p-labs (Life Sciences Platforms & Tools), ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
Medidata is recognized as a leading provider of SaaS solutions for clinical research.
1999New York, New York, United StatesUSD 41.5 M––
AI-based solutions for health management are provided.
2015Dallas, Texas, United StatesUSD 2.8 B––
Nanopore-based electronic systems for single-molecule analysis are developed.
2005Oxford, Oxfordshire, United KingdomUSD 1.3 BUSD 301.49 M1,480
Real-world health data is provided for research and decisions.
2012Menlo Park, California, United StatesUSD 259.16 M––
Genetically modified cell lines are developed using AAV gene-editing platform.
2007Cambridge, Cambridgeshire, United KingdomUSD 46.29 M––
Biological reagents and antibodies are developed for life science research.
1998Cambridge, Cambridgeshire, United KingdomUSD 78.8 M––
Electron microscopy services and microanalysis instruments are provided.
1956Waltham, Massachusetts, United States–USD 44.56 B125,000
Novel therapeutics are discovered using an AI-enabled drug platform.
2013New York, New York, United StatesUSD 456.66 MUSD 74.68 M–
A platform for sharing and accessing academic research papers is provided.
2008San Francisco, California, United StatesUSD 58.4 M––
Developer of molecular diagnostic testing solutions
1996Sunnyvale, California, United StatesUSD 19.1 MUSD 54.88 M208
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • ✓
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • ✓
    Full access to every database India & global coverage, advanced filters and rich profile details
  • ✓
    Always-on access from your team account Single premium plan for everything you see on the portal

Frequently Asked Questions about m2p-labs

m2p-labs was founded in 2005 and raised its 1st funding round 3 years after it was founded.

m2p-labs is headquartered in Baesweiler, Germany. It is registered at Baesweiler, North Rhine-westphalia, Germany.

m2p-labs has 107 employees.

Founded in 2005 in Baesweiler, Germany, m2p-labs operates within the biotech sector, specializing in biochemical engineering. Micro-reaction solutions are developed, including quantitative micro-bioreactor cultivation systems used for high-content screening and bioprocess development. Online monitoring technology is applied to microbial experiments under aerobic, microaerophilic, or anaerobic conditions. Products encompass microfluidic microbioreactors with pH and feeding controls, as well as systems for high-throughput fermentations that track biomass, pH, dissolved oxygen, and fluorescence.

m2p-labs's top competitors include PBS Biotech, Limula and Membio.

m2p-labs has 5 investors. Key investors include KfW, Beckman Coulter, FIDURA Private Equity Fonds, High-Tech Gründerfonds, and TechVision Fonds.

m2p-labs operates through M2p-Labs Gmbh.

Yes. m2p-labs was acquired by Beckman Coulter in November 2020.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available